Liver elastography
Authors:
Ondřej Bednář; Karel Dvořák
Authors‘ workplace:
Oddělení gastroenterologie a hepatologie, Krajská nemocnice Liberec, a. s.
Published in:
Čas. Lék. čes. 2022; 161: 61-64
Category:
Review Article
Overview
Liver elastography is a completely non-invasive method for examination of a stiffness of a liver parenchyma. It has been used worldwide and plays an essential role in detection and assessment of severity of liver fibrosis. Ultrasound based elastography methods – transient elastography (TE) and shear wave elastography (SWE) are the most widely used methods in clinical practice. Quick bedside examination, high reproducibility of results, availability and repeatability in time are among the benefits which led to a significant decrease in number of liver biopsies performed in last years. Elastography methods are also capable to evaluate presence of portal hypertension and risk of related complications in patients with liver cirrhosis noninvasively. Liver elastography represents an established diagnostic tool that has changed clinical practice in hepatology.
Keywords:
elastography – Cirrhosis – portal hypertension – fibrosis – liver stiffness
Sources
1. Poynard T, Ngo Y, Perazzo H et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol (NY) 2011; 7(7): 445–454.
2. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24(2): 289–293.
3. Seeff LB, Everson GT, Morgan TR et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010; 8(10): 877–883.
4. Dvorak K. Noninvasive diagnostics of liver diseases – imaging methods. Vnitřní lékařství 2019; 65(9): 539–545.
5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J Hepatol 2021; 75(3): 659–689.
6. Dietrich C, Bamber J, Berzigotti A et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017. Ultraschall Med 2017; 38(04): e16–e47.
7. Friedrich-Rust M, Nierhoff J, Lupsor M et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepa 2012; 19(2): e212–e219.
1. Poynard T, Ngo Y, Perazzo H et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol (NY) 2011; 7(7): 445–454.
2. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24(2): 289–293.
3. Seeff LB, Everson GT, Morgan TR et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010; 8(10): 877–883.
4. Dvorak K. Noninvasive diagnostics of liver diseases – imaging methods. Vnitřní lékařství 2019; 65(9): 539–545.
5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J Hepatol 2021; 75(3): 659–689.
6. Dietrich C, Bamber J, Berzigotti A et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017. Ultraschall Med 2017; 38(04): e16–e47.
7. Friedrich-Rust M, Nierhoff J, Lupsor M et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepa 2012; 19(2): e212–e219.
8. Tsochatzis EA, Gurusamy KS, Ntaoula S et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54(4): 650–659.
9. Husa P, Šperl J, Urbánek P a kol. Doporučený postup diagnostiky a léčby infekce virem hepatitidy B. Klinická mikrobiologie a infekční lékařství 2017; 23(4): 148–164.
10. Urbánek P, Husa P, Šperl J et al. Standardní diagnostický a terapeutický postup chronické infekce virem hepatitidy C (HCV). Klinická mikrobiologie a infekční lékařství 2017; 23(1): 22-40.
11. de Franchis R, Bosch J, Garcia-Tsao G et al. Baveno VII – renewing consensus in portal hypertension. J Hepatol 2022; 76(4): 959–974.
12. Maurice JB, Brodkin E, Arnold F et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol 2016; 65(5): 899–905.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
2022 Issue 2
Most read in this issue